Abingdon Health Plc
ABDX.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | £25,666 | £31,235 | £36,484 | £32,078 |
| - Cash | £1,918 | £1,440 | £3,236 | £2,397 |
| + Debt | £1,028 | £1,049 | £1,019 | £1,280 |
| Enterprise Value | £24,776 | £30,844 | £34,267 | £30,961 |
| Revenue | £8,429 | £6,135 | £4,045 | £2,835 |
| % Growth | 37.4% | 51.7% | 42.7% | – |
| Gross Profit | £3,128 | £3,679 | £1,402 | -£5,229 |
| % Margin | 37.1% | 60% | 34.7% | -184.4% |
| EBITDA | -£3,122 | -£916 | -£2,811 | -£19,979 |
| % Margin | -37% | -14.9% | -69.5% | -704.7% |
| Net Income | -£3,415 | -£1,271 | -£3,469 | -£21,262 |
| % Margin | -40.5% | -20.7% | -85.8% | -750% |
| EPS Diluted | -0.009 | -0.004 | -0.011 | -0.073 |
| % Growth | -121.4% | 63.2% | 84.4% | – |
| Operating Cash Flow | -£3,105 | -£1,659 | £1,002 | -£7,735 |
| Capital Expenditures | -£327 | -£41 | -£157 | -£760 |
| Free Cash Flow | -£3,432 | -£1,700 | £845 | -£8,495 |